Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Catheter PrecisionVTAK +6.82%27 EV-to-OCF is -1.30 as of Sep. 06, 2026. GuruFocus rates VTAK with a GF Score™ of 27/100 and a GF Value™ of $1.53 (Possible Value Trap). The stock has 9 warning signs investors should review. Among 850 Medical Devices & Instruments companies, Catheter Precision ranks better than 64.35% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Catheter Precision's Enterprise Value is $12.15 Mil.
Catheter Precision's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was $-9.35 Mil. Therefore, Catheter Precision's EV-to-OCF for today is -1.30.
The historical rank and industry rank for Catheter Precision's EV-to-OCF or its related term are showing as below:
VTAK'
s EV-to-OCF Range Over the Past 10 Years
Min: -1.57 Med: -0.18 Max: 0.57
Current: -1.3
During the past 10 years, the highest EV-to-OCF of Catheter Precision was 0.57. The lowest was -1.57. And the median was -0.18.
VTAK's EV-to-OCF is ranked better than 64.35% of 850
companies
in the Medical Devices & Instruments industry
Industry Median: 8.045
vs VTAK: -1.30
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Catheter Precision's PE Ratio (TTM) for today is calculated as:
Catheter Precision's share price for today is $0.21.
Catheter Precision's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-7.333.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Catheter Precision EV-to-OCF Related Terms
Catheter Precision EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Catheter Precision's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Catheter Precision's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Catheter Precision's EV-to-OCF falls into.
Catheter Precision's current Enterprise Value is $12.15 Mil.
Catheter Precision's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.35 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Catheter Precision (VTAK) has a EV-to-OCF of -1.30 as of Sep. 06, 2026. According to the industry distribution chart, Catheter Precision ranks #303 out of 850 companies in the Medical Devices & Instruments industry, placing it in the top 35.6%.
Is Catheter Precision's EV-to-OCF too high?
Catheter Precision's current EV-to-OCF is -1.30. Based on the distribution chart, Catheter Precision ranks #303 out of 850 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Catheter Precision has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Catheter Precision's EV-to-OCF compare to ODYY and BJDX?
According to the Medical Devices & Instruments industry distribution chart, Catheter Precision ranks #303 out of 850 companies for EV-to-OCF. This puts Catheter Precision in the upper half of its industry. The industry median EV-to-OCF is 8.05. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 8.05, based on 850 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 8.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Catheter Precision's current EV-to-OCF is -1.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Catheter Precision stock overvalued right now?
Based on GuruFocus' analysis, Catheter Precision (VTAK) is currently considered Possible Value Trap. The stock's GF Value™ is $1.53, compared to a current price of $0.21 — trading 86.3% below its estimated fair value. The current EV-to-OCF is -1.30. Catheter Precision's overall GF Score™ is 27/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Catheter Precision (VTAK), the current EV-to-OCF is -1.30 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Catheter Precision (VTAK) Overvalued in 2026?
Based on GuruFocus' analysis, Catheter Precision stock appears to be undervalued.
The current stock price of $0.21 is trading 86.3% below its estimated GF Value™ of $1.53.
GuruFocus considers Catheter Precision to be Possible Value Trap.
Key valuation signals for VTAK:
EV-to-OCF: -1.30
GF Value™: $1.53 vs. price of $0.21 (86.3% below fair value)
No single metric tells the full story. See the VTAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Catheter Precision Inc is engaged in the design, manufacture, and sale of medical technologies focused in the field of cardiac electrophysiology, or EP. The company's two primary products include the VIVO System and LockeT. The VIVO System, which is an acronym for View into Ventricular Onset System(VIVO or VIVO System), is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its newest product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure.
27GF Score
Get the complete analysis for VTAK
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
VTAK has been successfully added to your 
